Peer Reviewed

1

Document Type

Article

Publication Date

1-11-2013

Keywords

Animals, Brain Neoplasms, Disease Progression, Glioblastoma, Humans, Molecular Imaging, Neoplasm Recurrence, Local

Funder/Sponsor

Funding is acknowledged within the context of the Irish National Biophotonics and Imaging Platform and the European Commission Framework Programme 7 AngioTox and AngioPredict initiatives

Comments

This article is also available at http://europepmc.org/abstract/MED/23792334

Abstract

Current therapeutic strategies against glioblastoma (GBM) have failed to prevent disease progression and recurrence effectively. The part played by molecular imaging (MI) in the development of novel therapies has gained increasing traction in recent years. For the first time, using expertise from an integrated multidisciplinary group of authors, herein we present a comprehensive evaluation of state-of-the-art GBM imaging and explore how advances facilitate the emergence of new treatment options. We propose a novel next-generation treatment paradigm based on the targeting of multiple hallmarks of cancer evolution that will heavily rely on MI.

Disciplines

Physics | Physiology

Citation

Jarzabek MA , Sweeney KJ , Evans RL , Jacobs AH , Stupp R , O'Brien D , Berger MS , Prehn JH , Byrne AT. Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary. Drug Discovery Today. 2013;18(21-22):1052-1066.

PubMed ID

23792334

DOI Link

10.1016/j.drudis.2013.06.004

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.

Share

COinS